LBTSFOTCHealthcare · Drug Manufacturers - Specialty & Generic

Almirall, S.A.

$15.35-0.78%($-0.12)

TickerSpark Score

87/100

Strong

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LBTSF research report →

52-Week Range98% of range

Low $9.01

Current $15.35

High $15.47

Companywww.almirall.com

Almirall, S. A. , a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally.

CEO: Carlos Gallardo Piqué
IPO: 2012
Employees: 2,026
HQ: Barcelona, ES

Price Chart

+70.37% · this period

Valuation

Market Cap: $3.29B
P/E: 46.71
P/S: 1.78
P/B: 1.62
EV/EBITDA: 5.29
Div Yield: 1.33%

Profitability

Gross Margin: 67.13%
Op Margin: 18.93%
Net Margin: 3.82%
ROE: 3.53%
ROIC: 8.08%

Growth & Income

Revenue: $1.11B · 12.37%
Net Income: $46.18M · 355.14%
EPS: $0.21 · 384.99%
Op Income: $67.69M
FCF YoY: 20316.67%

Performance & Tape

52W High: $15.47
52W Low: $9.01
50D MA: $14.96
200D MA: $12.80
Beta: 0.20
Avg Volume: 173

Get TickerSpark's AI analysis on LBTSF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime